Tamir Kanias
Concepts (275)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Erythrocytes | 49 | 2026 | 751 | 8.410 |
Why?
| | Blood Preservation | 43 | 2025 | 346 | 6.500 |
Why?
| | Blood Donors | 26 | 2025 | 144 | 5.650 |
Why?
| | Hemolysis | 29 | 2025 | 242 | 4.170 |
Why?
| | Testosterone | 7 | 2024 | 413 | 3.270 |
Why?
| | Erythrocyte Transfusion | 17 | 2025 | 227 | 2.840 |
Why?
| | Biotin | 5 | 2026 | 32 | 1.290 |
Why?
| | Biotinylation | 4 | 2026 | 37 | 1.210 |
Why?
| | Hemoglobins | 9 | 2022 | 386 | 1.180 |
Why?
| | Oxidative Stress | 8 | 2024 | 1350 | 1.110 |
Why?
| | Hormone Replacement Therapy | 4 | 2024 | 107 | 1.080 |
Why?
| | Erythrocyte Deformability | 4 | 2025 | 23 | 1.030 |
Why?
| | Anemia, Sickle Cell | 6 | 2022 | 318 | 0.950 |
Why?
| | Hemoglobinopathies | 1 | 2022 | 6 | 0.740 |
Why?
| | Lipid Peroxidation | 4 | 2010 | 163 | 0.700 |
Why?
| | Metabolomics | 5 | 2020 | 729 | 0.630 |
Why?
| | Carnitine | 1 | 2020 | 91 | 0.620 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2024 | 2146 | 0.620 |
Why?
| | Nitric Oxide | 6 | 2020 | 894 | 0.610 |
Why?
| | Gonadal Steroid Hormones | 2 | 2019 | 143 | 0.570 |
Why?
| | Smokers | 1 | 2019 | 137 | 0.560 |
Why?
| | Cryopreservation | 3 | 2019 | 109 | 0.550 |
Why?
| | Smoke | 1 | 2019 | 148 | 0.540 |
Why?
| | Progesterone | 1 | 2019 | 209 | 0.540 |
Why?
| | Osmotic Pressure | 4 | 2022 | 41 | 0.510 |
Why?
| | Adult | 27 | 2025 | 40707 | 0.440 |
Why?
| | Flow Cytometry | 4 | 2026 | 1156 | 0.440 |
Why?
| | Male | 37 | 2025 | 72817 | 0.420 |
Why?
| | Vasoconstriction | 2 | 2013 | 216 | 0.420 |
Why?
| | Humans | 59 | 2026 | 145491 | 0.410 |
Why?
| | Pneumonia, Staphylococcal | 4 | 2015 | 27 | 0.400 |
Why?
| | Sex Factors | 4 | 2025 | 2110 | 0.400 |
Why?
| | Genomics | 1 | 2019 | 834 | 0.400 |
Why?
| | Cell Survival | 3 | 2025 | 1094 | 0.370 |
Why?
| | Endothelium-Dependent Relaxing Factors | 1 | 2012 | 17 | 0.370 |
Why?
| | Middle Aged | 20 | 2025 | 36176 | 0.360 |
Why?
| | Glucosephosphate Dehydrogenase | 2 | 2024 | 70 | 0.360 |
Why?
| | Phosphatidylserines | 2 | 2009 | 61 | 0.350 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2012 | 203 | 0.350 |
Why?
| | Blood Platelets | 2 | 2024 | 380 | 0.330 |
Why?
| | Mice | 11 | 2024 | 18338 | 0.330 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2012 | 185 | 0.330 |
Why?
| | Female | 31 | 2025 | 78763 | 0.330 |
Why?
| | Oxidation-Reduction | 5 | 2020 | 1080 | 0.320 |
Why?
| | Pentose Phosphate Pathway | 2 | 2020 | 55 | 0.320 |
Why?
| | Exchange Transfusion, Whole Blood | 3 | 2015 | 19 | 0.310 |
Why?
| | Blood Banks | 3 | 2020 | 50 | 0.310 |
Why?
| | Obesity | 2 | 2020 | 3076 | 0.310 |
Why?
| | Cold Temperature | 4 | 2025 | 209 | 0.300 |
Why?
| | Leupeptins | 1 | 2009 | 13 | 0.290 |
Why?
| | Animals | 20 | 2024 | 38141 | 0.290 |
Why?
| | Disaccharides | 1 | 2009 | 21 | 0.290 |
Why?
| | Transfusion Medicine | 2 | 2019 | 17 | 0.290 |
Why?
| | Trehalose | 1 | 2008 | 35 | 0.280 |
Why?
| | Erythrocyte Membrane | 3 | 2020 | 54 | 0.270 |
Why?
| | Mice, Inbred Strains | 2 | 2020 | 396 | 0.270 |
Why?
| | Glucosephosphate Dehydrogenase Deficiency | 2 | 2024 | 34 | 0.240 |
Why?
| | Metabolome | 2 | 2020 | 387 | 0.240 |
Why?
| | Glucose | 2 | 2021 | 1039 | 0.220 |
Why?
| | Iron | 3 | 2018 | 359 | 0.220 |
Why?
| | Hemorheology | 1 | 2025 | 24 | 0.220 |
Why?
| | Blood Specimen Collection | 2 | 2016 | 37 | 0.220 |
Why?
| | Plasma | 2 | 2019 | 225 | 0.220 |
Why?
| | Aged | 8 | 2024 | 26125 | 0.200 |
Why?
| | DNA, Mitochondrial | 1 | 2025 | 212 | 0.200 |
Why?
| | Methemoglobin | 3 | 2013 | 24 | 0.200 |
Why?
| | Diamide | 1 | 2022 | 4 | 0.190 |
Why?
| | Anion Exchange Protein 1, Erythrocyte | 1 | 2022 | 23 | 0.190 |
Why?
| | Extracellular Vesicles | 1 | 2025 | 171 | 0.190 |
Why?
| | Reactive Oxygen Species | 3 | 2010 | 602 | 0.180 |
Why?
| | Osmotic Fragility | 2 | 2019 | 12 | 0.180 |
Why?
| | Young Adult | 9 | 2025 | 14192 | 0.180 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2022 | 126 | 0.180 |
Why?
| | Mice, Inbred NOD | 2 | 2020 | 613 | 0.180 |
Why?
| | src-Family Kinases | 1 | 2022 | 92 | 0.180 |
Why?
| | Masculinity | 1 | 2021 | 11 | 0.170 |
Why?
| | Time Factors | 10 | 2022 | 7171 | 0.170 |
Why?
| | Oxyhemoglobins | 2 | 2013 | 28 | 0.170 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2022 | 265 | 0.170 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2022 | 287 | 0.170 |
Why?
| | Glycolysis | 2 | 2020 | 342 | 0.170 |
Why?
| | Age Factors | 4 | 2025 | 3340 | 0.170 |
Why?
| | Erucic Acids | 1 | 2020 | 3 | 0.170 |
Why?
| | Hematologic Tests | 1 | 2020 | 21 | 0.160 |
Why?
| | Enzyme Activation | 1 | 2022 | 762 | 0.160 |
Why?
| | Leukocyte Reduction Procedures | 1 | 2020 | 29 | 0.160 |
Why?
| | Ferritins | 1 | 2020 | 70 | 0.160 |
Why?
| | Xanthine | 1 | 2020 | 7 | 0.160 |
Why?
| | Coffee | 1 | 2020 | 15 | 0.160 |
Why?
| | Membrane Lipids | 1 | 2020 | 82 | 0.160 |
Why?
| | Polycythemia | 1 | 2020 | 25 | 0.160 |
Why?
| | Cell Membrane Permeability | 3 | 2009 | 87 | 0.150 |
Why?
| | Gamma Rays | 1 | 2020 | 57 | 0.150 |
Why?
| | Taurine | 1 | 2020 | 41 | 0.150 |
Why?
| | Caffeine | 1 | 2020 | 74 | 0.150 |
Why?
| | Chromatography, Liquid | 1 | 2021 | 445 | 0.150 |
Why?
| | Blood Component Transfusion | 1 | 2020 | 104 | 0.150 |
Why?
| | Metabolic Networks and Pathways | 1 | 2020 | 187 | 0.150 |
Why?
| | Purines | 1 | 2020 | 187 | 0.150 |
Why?
| | Succinimides | 1 | 2019 | 21 | 0.150 |
Why?
| | Hypogonadism | 1 | 2020 | 90 | 0.150 |
Why?
| | Arginine | 1 | 2020 | 238 | 0.150 |
Why?
| | Erythrocytes, Abnormal | 2 | 2016 | 14 | 0.140 |
Why?
| | Glutathione | 1 | 2020 | 366 | 0.140 |
Why?
| | Asparagine | 1 | 2018 | 34 | 0.140 |
Why?
| | Donor Selection | 1 | 2019 | 81 | 0.140 |
Why?
| | Cigarette Smoking | 1 | 2020 | 101 | 0.140 |
Why?
| | Models, Animal | 1 | 2020 | 395 | 0.140 |
Why?
| | Aspartic Acid | 1 | 2018 | 87 | 0.140 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2020 | 581 | 0.140 |
Why?
| | Sex Characteristics | 1 | 2024 | 779 | 0.140 |
Why?
| | Tandem Mass Spectrometry | 1 | 2021 | 566 | 0.140 |
Why?
| | Blood | 1 | 2018 | 107 | 0.140 |
Why?
| | Multivariate Analysis | 2 | 2018 | 1544 | 0.140 |
Why?
| | In Vitro Techniques | 3 | 2021 | 1047 | 0.140 |
Why?
| | Phosphorylation | 1 | 2022 | 1707 | 0.130 |
Why?
| | Dopamine | 1 | 2020 | 295 | 0.130 |
Why?
| | Hemoglobinuria | 2 | 2015 | 5 | 0.130 |
Why?
| | Nicotine | 1 | 2020 | 334 | 0.130 |
Why?
| | Fatty Acids | 1 | 2020 | 459 | 0.130 |
Why?
| | Mass Spectrometry | 1 | 2020 | 744 | 0.130 |
Why?
| | Sickle Cell Trait | 1 | 2016 | 15 | 0.120 |
Why?
| | Genome, Human | 1 | 2018 | 420 | 0.120 |
Why?
| | Menopause | 1 | 2019 | 319 | 0.120 |
Why?
| | Blood Transfusion, Autologous | 1 | 2015 | 18 | 0.120 |
Why?
| | Protein Processing, Post-Translational | 1 | 2018 | 468 | 0.120 |
Why?
| | Dogs | 5 | 2015 | 438 | 0.110 |
Why?
| | Calcium | 2 | 2019 | 1190 | 0.110 |
Why?
| | Vasoconstrictor Agents | 2 | 2019 | 150 | 0.110 |
Why?
| | Socioeconomic Factors | 1 | 2020 | 1327 | 0.110 |
Why?
| | Nitroprusside | 1 | 2015 | 71 | 0.110 |
Why?
| | Cohort Studies | 3 | 2021 | 5992 | 0.110 |
Why?
| | Canada | 1 | 2016 | 434 | 0.110 |
Why?
| | Genome-Wide Association Study | 4 | 2024 | 1378 | 0.110 |
Why?
| | Precision Medicine | 1 | 2019 | 456 | 0.110 |
Why?
| | Hypoxia | 1 | 2022 | 1199 | 0.110 |
Why?
| | Endothelial Cells | 2 | 2023 | 866 | 0.110 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2015 | 79 | 0.100 |
Why?
| | Acute Lung Injury | 2 | 2014 | 301 | 0.100 |
Why?
| | Cell-Derived Microparticles | 2 | 2012 | 72 | 0.100 |
Why?
| | Pilot Projects | 1 | 2019 | 1896 | 0.100 |
Why?
| | Smoking | 1 | 2020 | 1468 | 0.090 |
Why?
| | Prevalence | 1 | 2020 | 2855 | 0.090 |
Why?
| | Staphylococcus aureus | 2 | 2014 | 455 | 0.090 |
Why?
| | Kinetics | 3 | 2022 | 1605 | 0.090 |
Why?
| | Case-Control Studies | 1 | 2020 | 3619 | 0.090 |
Why?
| | Body Mass Index | 1 | 2020 | 2425 | 0.090 |
Why?
| | Transfusion Reaction | 1 | 2012 | 61 | 0.090 |
Why?
| | Haptoglobins | 1 | 2012 | 71 | 0.090 |
Why?
| | United States | 3 | 2020 | 16115 | 0.090 |
Why?
| | Free Radical Scavengers | 1 | 2011 | 82 | 0.080 |
Why?
| | Kidney Diseases | 1 | 2015 | 427 | 0.080 |
Why?
| | Retrospective Studies | 3 | 2024 | 17269 | 0.080 |
Why?
| | Osmosis | 2 | 2022 | 22 | 0.080 |
Why?
| | Genetic Variation | 1 | 2015 | 988 | 0.080 |
Why?
| | Cryoprotective Agents | 1 | 2009 | 11 | 0.080 |
Why?
| | Dehydration | 1 | 2010 | 59 | 0.080 |
Why?
| | Protein Denaturation | 1 | 2009 | 72 | 0.080 |
Why?
| | Desiccation | 1 | 2009 | 26 | 0.080 |
Why?
| | Aged, 80 and over | 2 | 2019 | 8326 | 0.080 |
Why?
| | Adolescent | 6 | 2025 | 22485 | 0.080 |
Why?
| | Thiobarbiturates | 1 | 2009 | 1 | 0.070 |
Why?
| | Fluorescent Dyes | 2 | 2022 | 335 | 0.070 |
Why?
| | Thiobarbituric Acid Reactive Substances | 1 | 2009 | 28 | 0.070 |
Why?
| | Malondialdehyde | 1 | 2009 | 30 | 0.070 |
Why?
| | Stress, Physiological | 1 | 2012 | 452 | 0.070 |
Why?
| | Antioxidants | 2 | 2024 | 549 | 0.070 |
Why?
| | Reference Values | 1 | 2010 | 797 | 0.070 |
Why?
| | Genotype | 3 | 2018 | 1853 | 0.070 |
Why?
| | Hydrogen Peroxide | 1 | 2009 | 338 | 0.070 |
Why?
| | Quality Control | 2 | 2018 | 164 | 0.060 |
Why?
| | Disease Models, Animal | 5 | 2016 | 4559 | 0.060 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2013 | 663 | 0.060 |
Why?
| | Cell Membrane | 1 | 2010 | 707 | 0.060 |
Why?
| | Staining and Labeling | 1 | 2026 | 153 | 0.060 |
Why?
| | Temperature | 1 | 2008 | 681 | 0.060 |
Why?
| | Tilapia | 1 | 2005 | 1 | 0.060 |
Why?
| | Mice, Knockout | 1 | 2012 | 3125 | 0.060 |
Why?
| | Saponins | 1 | 2005 | 12 | 0.050 |
Why?
| | Plateletpheresis | 1 | 2024 | 28 | 0.050 |
Why?
| | Rheology | 1 | 2025 | 94 | 0.050 |
Why?
| | Pituitary Gland | 1 | 2005 | 148 | 0.050 |
Why?
| | Platelet Activation | 1 | 2024 | 98 | 0.050 |
Why?
| | Kidney | 1 | 2012 | 1498 | 0.050 |
Why?
| | Hemostasis | 1 | 2024 | 98 | 0.050 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2024 | 563 | 0.050 |
Why?
| | Quantitative Trait Loci | 1 | 2025 | 375 | 0.050 |
Why?
| | Cytoplasm | 1 | 2023 | 257 | 0.050 |
Why?
| | Survival Analysis | 2 | 2018 | 1374 | 0.050 |
Why?
| | Kv1.6 Potassium Channel | 1 | 2022 | 1 | 0.050 |
Why?
| | Random Allocation | 2 | 2013 | 366 | 0.040 |
Why?
| | Models, Biological | 1 | 2009 | 1815 | 0.040 |
Why?
| | Oxygen Consumption | 1 | 2024 | 718 | 0.040 |
Why?
| | Cellular Senescence | 1 | 2024 | 225 | 0.040 |
Why?
| | Leukocyte Transfusion | 1 | 2020 | 5 | 0.040 |
Why?
| | Linkage Disequilibrium | 1 | 2021 | 249 | 0.040 |
Why?
| | Phosphates | 1 | 2021 | 177 | 0.040 |
Why?
| | Heterografts | 1 | 2020 | 143 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 2 | 2021 | 2355 | 0.040 |
Why?
| | Multifactorial Inheritance | 1 | 2021 | 190 | 0.040 |
Why?
| | Mice, SCID | 1 | 2020 | 369 | 0.040 |
Why?
| | Platelet Transfusion | 1 | 2020 | 78 | 0.040 |
Why?
| | Streptavidin | 1 | 2019 | 15 | 0.040 |
Why?
| | Plasticizers | 1 | 2019 | 18 | 0.040 |
Why?
| | Signal-To-Noise Ratio | 1 | 2019 | 73 | 0.040 |
Why?
| | Child | 1 | 2019 | 22680 | 0.040 |
Why?
| | Fetal Hemoglobin | 1 | 2018 | 8 | 0.040 |
Why?
| | Oxidants | 1 | 2019 | 103 | 0.040 |
Why?
| | Sex Chromosomes | 1 | 2018 | 53 | 0.030 |
Why?
| | Healthy Volunteers | 1 | 2019 | 218 | 0.030 |
Why?
| | Methylation | 1 | 2018 | 242 | 0.030 |
Why?
| | Transplantation, Autologous | 1 | 2019 | 298 | 0.030 |
Why?
| | Methionine | 1 | 2018 | 162 | 0.030 |
Why?
| | Gene Frequency | 1 | 2018 | 483 | 0.030 |
Why?
| | Evolution, Molecular | 1 | 2021 | 518 | 0.030 |
Why?
| | Hemoglobin A | 1 | 2016 | 21 | 0.030 |
Why?
| | Immunologic Factors | 1 | 2019 | 260 | 0.030 |
Why?
| | Clodronic Acid | 1 | 2016 | 19 | 0.030 |
Why?
| | Splenectomy | 1 | 2016 | 61 | 0.030 |
Why?
| | Adenosine Triphosphate | 1 | 2018 | 503 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2019 | 505 | 0.030 |
Why?
| | Hematocrit | 1 | 2016 | 108 | 0.030 |
Why?
| | Phenotype | 1 | 2024 | 3157 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2018 | 1304 | 0.030 |
Why?
| | Apolipoprotein L1 | 1 | 2015 | 14 | 0.030 |
Why?
| | Severity of Illness Index | 2 | 2014 | 2945 | 0.030 |
Why?
| | Apolipoproteins | 1 | 2015 | 38 | 0.030 |
Why?
| | Plethysmography | 1 | 2015 | 104 | 0.030 |
Why?
| | Hepatitis A Virus Cellular Receptor 1 | 1 | 2015 | 43 | 0.030 |
Why?
| | Pennsylvania | 1 | 2015 | 138 | 0.030 |
Why?
| | Leukocyte Count | 1 | 2016 | 316 | 0.030 |
Why?
| | Heme Oxygenase-1 | 1 | 2015 | 74 | 0.030 |
Why?
| | Receptors, Virus | 1 | 2015 | 96 | 0.030 |
Why?
| | Acetylcholine | 1 | 2015 | 208 | 0.030 |
Why?
| | Lipoproteins, HDL | 1 | 2015 | 99 | 0.030 |
Why?
| | Osmolar Concentration | 1 | 2015 | 169 | 0.030 |
Why?
| | Kidney Tubules, Proximal | 1 | 2015 | 130 | 0.030 |
Why?
| | Potassium | 1 | 2015 | 153 | 0.030 |
Why?
| | Cell Separation | 1 | 2015 | 304 | 0.030 |
Why?
| | Computational Biology | 1 | 2018 | 687 | 0.020 |
Why?
| | Calcium Signaling | 1 | 2015 | 244 | 0.020 |
Why?
| | Aging | 1 | 2024 | 1940 | 0.020 |
Why?
| | Erythrocyte Indices | 1 | 2012 | 33 | 0.020 |
Why?
| | Albuminuria | 1 | 2013 | 190 | 0.020 |
Why?
| | Pulmonary Gas Exchange | 1 | 2012 | 116 | 0.020 |
Why?
| | Membrane Glycoproteins | 1 | 2015 | 496 | 0.020 |
Why?
| | Albumins | 1 | 2013 | 119 | 0.020 |
Why?
| | Vasodilation | 1 | 2015 | 521 | 0.020 |
Why?
| | Single-Blind Method | 1 | 2012 | 319 | 0.020 |
Why?
| | Proteomics | 1 | 2018 | 1191 | 0.020 |
Why?
| | Europe | 1 | 2012 | 421 | 0.020 |
Why?
| | Down-Regulation | 1 | 2013 | 616 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2016 | 2189 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2018 | 3424 | 0.020 |
Why?
| | Gene Expression | 1 | 2015 | 1478 | 0.020 |
Why?
| | Rats, Wistar | 1 | 2011 | 449 | 0.020 |
Why?
| | Glomerular Filtration Rate | 1 | 2013 | 765 | 0.020 |
Why?
| | Mortality | 1 | 2012 | 379 | 0.020 |
Why?
| | Cell Line | 1 | 2015 | 2823 | 0.020 |
Why?
| | Risk Factors | 2 | 2014 | 10874 | 0.020 |
Why?
| | Treatment Outcome | 2 | 2014 | 11831 | 0.020 |
Why?
| | Heart Rate | 1 | 2012 | 859 | 0.020 |
Why?
| | Comorbidity | 1 | 2012 | 1659 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 5891 | 0.020 |
Why?
| | Blood Pressure | 1 | 2013 | 1782 | 0.010 |
Why?
| | Disease Progression | 1 | 2013 | 2862 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2018 | 6070 | 0.010 |
Why?
| | Quillaja | 1 | 2005 | 1 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2013 | 5426 | 0.010 |
Why?
| | Plant Extracts | 1 | 2005 | 188 | 0.010 |
Why?
| | Rats | 1 | 2011 | 5581 | 0.010 |
Why?
| | Hypertension, Pulmonary | 1 | 2012 | 1957 | 0.010 |
Why?
| | Biomarkers | 1 | 2012 | 4283 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2005 | 2030 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2005 | 4127 | 0.010 |
Why?
|
|
Kanias's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|